IP-10 induces dissociation of newly formed blood vessels
暂无分享,去创建一个
Alan Wells | Xiaoping Du | Richard J Bodnar | Cecelia C Yates | R. Bodnar | A. Wells | Xiaoping Du | Margaret E Rodgers | C. Yates | M. Rodgers
[1] R. Bodnar,et al. Critical roles for the COOH-terminal NITY and RGT sequences of the integrin β3 cytoplasmic domain in inside-out and outside-in signaling , 2003, The Journal of cell biology.
[2] T. Veikkola,et al. Interaction of endostatin with integrins implicated in angiogenesis. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[3] P. Hebda,et al. ELR-negative CXC chemokine CXCL11 (IP-9/I-TAC) facilitates dermal and epidermal maturation during wound repair. , 2008, The American journal of pathology.
[4] P. Flevaris,et al. Tyrosine Phosphorylation of the Integrin β3 Subunit Regulates β3 Cleavage by Calpain* , 2006, Journal of Biological Chemistry.
[5] Sergio Romagnani,et al. An Alternatively Spliced Variant of CXCR3 Mediates the Inhibition of Endothelial Cell Growth Induced by IP-10, Mig, and I-TAC, and Acts as Functional Receptor for Platelet Factor 4 , 2003, The Journal of experimental medicine.
[6] M. Burdick,et al. CXCL11 attenuates bleomycin-induced pulmonary fibrosis via inhibition of vascular remodeling. , 2005, American journal of respiratory and critical care medicine.
[7] C. Ruhrberg,et al. Endogenous inhibitors of angiogenesis. , 2001, Journal of cell science.
[8] M. Nose,et al. Accumulation of plasma cells expressing CXCR3 in the synovial sublining regions of early rheumatoid arthritis in association with production of Mig/CXCL9 by synovial fibroblasts , 2005, Clinical and experimental immunology.
[9] K. Yamaguchi,et al. Platelet factor 4 gene transfection into tumor cells inhibits angiogenesis, tumor growth and metastasis. , 2005, Anticancer research.
[10] P. Romagnani,et al. CXCR3-binding chemokines: novel multifunctional therapeutic targets. , 2005, Current drug targets. Immune, endocrine and metabolic disorders.
[11] B. Sykes,et al. The CXCR3 binding chemokine IP-10/CXCL10: structure and receptor interactions. , 2002, Biochemistry.
[12] R. Bodnar,et al. Delayed and deficient dermal maturation in mice lacking the CXCR3 ELR-negative CXC chemokine receptor. , 2007, The American journal of pathology.
[13] D. Pode,et al. Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal. , 1999, The Journal of clinical investigation.
[14] R. Bodnar,et al. IP-10 Blocks Vascular Endothelial Growth Factor-Induced Endothelial Cell Motility and Tube Formation via Inhibition of Calpain , 2006, Circulation research.
[15] M. Burdick,et al. Platelet factor-4 variant chemokine CXCL4L1 inhibits melanoma and lung carcinoma growth and metastasis by preventing angiogenesis. , 2007, Cancer research.
[16] A. Feldman,et al. Interferon γ–Inducible Protein 10 Selectively Inhibits Proliferation and Induces Apoptosis in Endothelial Cells , 2006, Annals of Surgical Oncology.
[17] E. Jaffe,et al. Anti-tumor activities of the angiogenesis inhibitors interferon-inducible protein-10 and the calreticulin fragment vasostatin , 2002, Cancer Immunology, Immunotherapy.
[18] R. Bodnar,et al. Epidermal Growth Factor Activates m-Calpain (Calpain II), at Least in Part, by Extracellular Signal-Regulated Kinase-Mediated Phosphorylation , 2004, Molecular and Cellular Biology.
[19] R. Swerlick,et al. HMEC-1: establishment of an immortalized human microvascular endothelial cell line. , 1992, The Journal of investigative dermatology.
[20] Andrew P. McMahon,et al. WNT7b mediates macrophage-induced programmed cell death in patterning of the vasculature , 2005, Nature.
[21] C. Tait,et al. Angiopoietins in tumours: the angiogenic switch , 2004, The Journal of pathology.
[22] G. Davis,et al. Molecular balance of capillary tube formation versus regression in wound repair: role of matrix metalloproteinases and their inhibitors. , 2006, The journal of investigative dermatology. Symposium proceedings.
[23] W. Hancock,et al. Requirement of the Chemokine Receptor CXCR3 for Acute Allograft Rejection , 2000, The Journal of experimental medicine.
[24] A. Richmond,et al. The angiostatic activity of interferon-inducible protein-10/CXCL10 in human melanoma depends on binding to CXCR3 but not to glycosaminoglycan. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.
[25] M. Serio,et al. Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity. , 2001, The Journal of clinical investigation.
[26] T. Byzova,et al. Mechanisms of Integrin–Vascular Endothelial Growth Factor Receptor Cross-Activation in Angiogenesis , 2007, Circulation research.
[27] Xiaoping Du,et al. Cleavage of the Cytoplasmic Domain of the Integrin β3 Subunit during Endothelial Cell Apoptosis* , 1998, Journal of Biological Chemistry.
[28] George Kolios,et al. The Chemokines CXCL9, CXCL10, and CXCL11 Differentially Stimulate Gαi-Independent Signaling and Actin Responses in Human Intestinal Myofibroblasts1 , 2005, The Journal of Immunology.
[29] E. Hudson,et al. Differential expression and responsiveness of chemokine receptors (CXCR1–3) by human microvascular endothelial cells and umbilical vein endothelial cells , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[30] P. Carmeliet,et al. Targeted Deficiency or Cytosolic Truncation of the VE-cadherin Gene in Mice Impairs VEGF-Mediated Endothelial Survival and Angiogenesis , 1999, Cell.
[31] C. Craddock,et al. CXCL10-CXCR3 interactions play an important role in the pathogenesis of acute graft-versus-host disease in the skin following allogeneic stem-cell transplantation. , 2007, Blood.
[32] Jianhua Huang,et al. A Role for VEGF as a Negative Regulator of Pericyte Function and Vessel Maturation , 2008, Nature.
[33] O. Volpert,et al. Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1 , 2000, Nature Medicine.
[34] P. Flevaris,et al. A molecular switch that controls cell spreading and retraction , 2007, The Journal of cell biology.
[35] G. Brunner,et al. Extracellular regulation of TGF-β activity in wound repair: growth factor latency as a sensor mechanism for injury , 2004, Thrombosis and Haemostasis.
[36] P. Flevaris,et al. Tyrosine phosphorylation of the integrin beta 3 subunit regulates beta 3 cleavage by calpain. , 2006, The Journal of biological chemistry.
[37] Z. Jia,et al. Activation of m-Calpain (Calpain II) by Epidermal Growth Factor Is Limited by Protein Kinase A Phosphorylation of m-Calpain , 2002, Molecular and Cellular Biology.
[38] N. Giese,et al. Suppression of metastatic hemangiosarcoma by a parvovirus MVMp vector transducing the IP-10 chemokine into immunocompetent mice , 2002, Cancer Gene Therapy.
[39] A. Wells,et al. Interferon-Inducible Protein 9 (CXCL11)-Induced Cell Motility in Keratinocytes Requires Calcium Flux-Dependent Activation of μ-Calpain , 2005, Molecular and Cellular Biology.